AIN Holdings
Financials
Estimates*
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 297.3b | 316.2b | 358.7b | 399.8b | 426.0b | 441.9b | 466.0b |
| % growth | 2 % | 6 % | 13 % | 11 % | 7 % | 4 % | 5 % |
| EBITDA | 21.5b | 24.9b | 27.0b | 32.4b | 32.6b | 33.1b | 36.4b |
| % EBITDA margin | 7 % | 8 % | 8 % | 8 % | 8 % | 7 % | 8 % |
| Profit | 6.7b | 7.1b | 9.2b | 11.4b | 10.8b | 11.8b | 12.9b |
| % profit margin | 2 % | 2 % | 3 % | 3 % | 3 % | 3 % | 3 % |
| EV / revenue | 0.6x | 0.5x | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x |
| EV / EBITDA | 8.0x | 6.2x | 5.9x | 5.2x | 5.7x | 5.6x | 5.1x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
* | N/A | Post IPO Equity | |
| Total Funding | - | ||
Recent News about AIN Holdings
EditAIN HOLDINGS INC. operates as a leading pharmacy chain in Japan, providing a wide range of healthcare services and beauty products. The company serves a diverse clientele, including individual consumers seeking prescription medications, over-the-counter drugs, and beauty products. AIN HOLDINGS INC. operates in the retail healthcare market, leveraging its extensive network of pharmacies to reach customers across Japan. The business model focuses on retail sales through its physical stores and online platforms, generating revenue from the sale of pharmaceuticals, health-related products, and beauty items. The company also engages in strategic acquisitions to expand its market presence and enhance its service offerings.
Keywords: pharmacy, healthcare, beauty products, retail, Japan, prescription medications, over-the-counter drugs, acquisitions, online sales, strategic growth.
